These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19358337)

  • 41. Role of PKCdelta in IFN-gamma-inducible CIITA gene expression.
    Kwon MJ; Yao Y; Walter MJ; Holtzman MJ; Chang CH
    Mol Immunol; 2007 Apr; 44(11):2841-9. PubMed ID: 17346795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes.
    Lu Y; Tschickardt ME; Schmidt BJ; Blanck G
    Immunol Cell Biol; 1997 Aug; 75(4):325-32. PubMed ID: 9315472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.
    Steimle V; Siegrist CA; Mottet A; Lisowska-Grospierre B; Mach B
    Science; 1994 Jul; 265(5168):106-9. PubMed ID: 8016643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines.
    van der Stoep N; Biesta P; Quinten E; van den Elsen PJ
    Int J Cancer; 2002 Feb; 97(4):501-7. PubMed ID: 11802213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gamma interferon modulates myogenesis through the major histocompatibility complex class II transactivator, CIITA.
    Londhe P; Davie JK
    Mol Cell Biol; 2011 Jul; 31(14):2854-66. PubMed ID: 21576360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
    Murphy SP; Tomasi TB
    Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines.
    Tschickardt ME; Lu Y; Jacim M; Ussery GD; Steimle V; Mach B; Blanck G
    Int J Cancer; 1995 Aug; 62(4):461-5. PubMed ID: 7635572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA.
    Tang KC; Trzaska KA; Smirnov SV; Kotenko SV; Schwander SK; Ellner JJ; Rameshwar P
    J Immunol; 2008 Feb; 180(3):1826-33. PubMed ID: 18209080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Major histocompatibility class II transactivator expression in smooth muscle cells from A2b adenosine receptor knock-out mice: cross-talk between the adenosine and interferon-gamma signaling.
    Xu Y; Ravid K; Smith BD
    J Biol Chem; 2008 May; 283(21):14213-20. PubMed ID: 18359773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism.
    Willermain F; Dulku S; Gonzalez NS; Blero D; Driessens G; De Graef C; Caspers L; Bruyns C
    Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):136-43. PubMed ID: 16939878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ESAT6 differentially inhibits IFN-γ-inducible class II transactivator isoforms in both a TLR2-dependent and -independent manner.
    Kumar P; Agarwal R; Siddiqui I; Vora H; Das G; Sharma P
    Immunol Cell Biol; 2012 Apr; 90(4):411-20. PubMed ID: 21670739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
    Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
    Zhou X; Jiang Y; Lu L; Ding Q; Jiao Z; Zhou Y; Xin L; Chou KY
    Immunology; 2007 Dec; 122(4):476-85. PubMed ID: 17645498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
    Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
    Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
    Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
    Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
    Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
    J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE; Cooper S; Hangoc G; Chang CH
    Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transforming growth factor-beta/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells.
    Kanai H; Tanaka T; Aihara Y; Takeda S; Kawabata M; Miyazono K; Nagai R; Kurabayashi M
    Circ Res; 2001 Jan; 88(1):30-6. PubMed ID: 11139470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early stimulation and late inhibition of peroxisome proliferator-activated receptor gamma (PPAR gamma) gene expression by transforming growth factor beta in human aortic smooth muscle cells: role of early growth-response factor-1 (Egr-1), activator protein 1 (AP1) and Smads.
    Fu M; Zhang J; Lin Y; Zhu X; Zhao L; Ahmad M; Ehrengruber MU; Chen YE
    Biochem J; 2003 Mar; 370(Pt 3):1019-25. PubMed ID: 12457461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.